Results 191 to 200 of about 176,568 (258)

H1N1 influenza

, 2014
Yuranga Weerakkody, Joachim Feger, Dr Banerjee   +2 more
openaire   +1 more source

Epidemiological diversity of seasonal influenza and post-COVID-19 pandemic changes in the UK, 2015-2025: a surveillance-based analysis. [PDF]

BMC Public Health
Yuan L, Sun C, Wang H, Zeng Z.
europepmc   +1 more source

Unraveling A‐β+ ketosis‐prone diabetes: An evolving diagnosis with an elusive pathogenesis

Journal of Diabetes Investigation, Volume 17, Issue 3, Page 381-391, March 2026.
ABSTRACT Since the discovery of insulin over a century ago, how we conceptualize, describe and treat diabetes has evolved, paving the way for the identification of distinct diabetes subgroups and individualized treatment options. Historically, the term ketosis‐prone diabetes (KPD) has comprised a group of diabetes syndromes characterized by severe ...
Nina Suda, Gabrielle Page‐Wilson, Jacqueline Lonier, Utpal B. Pajvani   +3 more
wiley   +1 more source

Enolase 1 suppresses influenza A virus replication by blocking the nuclear import of the viral ribonucleoprotein complex. [PDF]

Cell Mol Life Sci
Kong X, Liu J, Zhu Q, Xu S.
europepmc   +1 more source

Avian influenza overview December 2025–February 2026

EFSA Journal, Volume 24, Issue 3, March 2026.
Abstract Between 29 November 2025 and 27 February 2026, 2514 highly pathogenic avian influenza (HPAI) A(H5) virus detections were reported in domestic (406) and wild (2108) birds in 32 countries in Europe. Albeit still at high levels after the peak was reached at the beginning of the current reporting period, the weekly number of detections has since ...
European Food Safety Authority (EFSA), European Centre for Disease Prevention and Control (ECDC), European Union Reference Laboratory for Avian Influenza (EURL), Cyril Barbezange, Hubert Buczkowski, Mariette Ducatez, Alice Fusaro, Jose L. Gonzales, Thijs Kuiken, Gražina Mirinavičiūtė, Karl Ståhl, Christoph Staubach, Olov Svartström, Calogero Terregino, Katriina Willgert, Evelyn Alarcón, Lisa Kohnle   +16 more
wiley   +1 more source

Intranasal vaccines adjuvanted with Nexavant demonstrate robust protective efficacy by inducing both mucosal and systemic immunity in a murine model. [PDF]

Front Immunol
Ko KH, Bae HS, Lee SM, Park S, Han SH, Heo J, Kim J, Cho Y, Kim DH, Cha SB.   +9 more
europepmc   +1 more source

Brixia score on initial chest X-ray as a predictor of outcome in COVID-19 and H1N1 acute chest infections: A retrospective study. [PDF]

Medicine (Baltimore)
Khasawneh R, Khassawneh B, Khasawneh FA, Gharaibeh M, Athamneh S, Ajam T, Nofal MZ.   +6 more
europepmc   +1 more source

TMPRSS2 inhibitors with broad-spectrum efficacy against SARS-CoV-2 (JN.1) and influenza A (H1N1) viruses protect mice from influenza A infection. [PDF]

Emerg Microbes Infect
Presley L, Pérez-Vargas J, Saintigny A, Villanueva I, Ho M, Fone J, Brinsden L, Kaushik N, Olver S, Thompson CAH, Bautista-Sánchez D, Ennis S, Chen M, McCallum M, Brown JT, Ferková S, Hetrick B, Veesler D, Leduc R, Niikura M, Boudreault PL, Warner B, Jean F.   +22 more
europepmc   +1 more source

An analysis of WHO FluNet and FluID influenza surveillance data for South East Asia Region, 2015-2023. [PDF]

PLoS One
Kakkar M, Sharma D, Pal M, Mohapatra A, Sedai TR, Inbanathan FY, Buddha N, Salvador EC, Wijesinghe PR.   +8 more
europepmc   +1 more source

H1N1 pneumonia

, 2020
openaire   +1 more source